CAPRCapricor Therapeutics, Inc.
MixedFDA action or review extension for Capricor's Deramiocel is due after a 3 to 9 negative panel vote
in 3h 25m
Friday, 21 August 2026
What is about to move US stocks
- ZYMEZymeworks Inc.Positive
FDA decision on Ziihera first-line gastric cancer expansion could unlock $250 million for Zymeworks
in 3d 3h - GILDGilead Sciences, Inc.Positive
FDA decision for Gilead’s once daily HIV pill BIC/LEN, PDUFA date August 27, 2026
in 5d 3h - TLXTelix Pharmaceuticals LimitedPositive
FDA decision on resubmitted Pixclara application could reset Telix growth expectations
in 20d 3h